ClinicalTrials.gov
public full text
Public Domain
Bioequivalence Study of Anastrozole 1 mg Tablet
The purpose of this study is to characterize and compare the bioequivalence of CJ anastrozole \[CJ Cheiljedang corp., Seoul, Korea\] with Arimidex® \[AstraZeneca, Wilmington, DE, USA\].
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- SEQUENTIAL INJECTION ANALYSIS (SIA) TECHNIQUE FOR THE ASSAY OF KETOCONAZOLE AND DICLOFENAC SODIUM IN DRUG FORMULATIONS WITH CHEMOMETRIC APPROACH#284577
- Bioequivalence Study of Letrozole 2.5 mg Tablets#1032948
- A Pilot Bioequivalence Study of Pomalidomide#864295
- Bioequivalence Study of Naproxen Sodium 550 mg Tablets Under Fasting Condition#891366
- Development of Fourier transform infrared spectrophotometric method for identification and determination of marketed metamizole tablet preparation#1023823
Record · ID 867019
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive